MedTrace Logo

Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction

NCT03021707 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2022-04-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the initial safety of the UV-FS laser in humans.

Conditions

  • Refractive Error - Myopia Severe
  • Refractive Error - Myopia Simple

Interventions

DEVICE

WaveLight® Ultraviolet Femtosecond (FS) Laser System

Utilizes ultraviolet (UV) light with a wavelength of 347 nanometers (nm) for refractive error correction

PROCEDURE

Laser Assisted Lenticular Extraction

Used for refractive error correction

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Manager, Surgical · Alcon Research

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-07
Primary Completion
2019-05-27
Completion
2019-10-17
FDA Device
Yes

Countries

  • United States
  • Ireland
  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03021707 on ClinicalTrials.gov